AI assistant
Sending…
GENELUX Corp — Director's Dealing 2023
Jan 26, 2023
33857_dirs_2023-01-25_3152b248-d802-4f48-add2-17a664b2086f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: GENELUX CORP (GNLX)
CIK: 0001231457
Period of Report: 2023-01-25
Reporting Person: Thomas John (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A Preferred Stock | $ | Common Stock (470000) | Direct | ||
| Stock Option (right to buy) | $9.00 | 2026-03-16 | Common Stock (5000) | Direct | |
| Stock Option (right to buy) | $9.00 | 2026-03-16 | Common Stock (10000) | Direct | |
| Stock Option (right to buy) | $9.00 | 2026-12-30 | Common Stock (5000) | Direct | |
| Stock Option (right to buy) | $10.50 | 2028-05-22 | Common Stock (5000) | Direct | |
| Stock Option (right to buy) | $10.50 | 2028-12-30 | Common Stock (9916) | Direct | |
| Stock Option (right to buy) | $10.50 | 2029-12-30 | Common Stock (9916) | Direct | |
| Stock Option (right to buy) | $10.50 | 2030-09-23 | Common Stock (10908) | Direct | |
| Stock Option (right to buy) | $10.50 | 2032-09-08 | Common Stock (25000) | Direct |
Footnotes
F1: The Series A Preferred Stock will automatically convert into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock immediately upon the closing of the Issuer's initial public offering. The Preferred Stock has no expiration date.
F2: Immediately exercisable.
More from GENELUX Corp
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Capital/Financing Update
2026
Mar 19
Capital/Financing Update
2026
Mar 19
Capital/Financing Update
2026
Mar 19
Director's Dealing
2026
Mar 4